| Dr Daniel E Marsh, MD | |
|
5238 Dijon Dr, Baton Rouge, LA 70808-4311 | |
| (225) 526-0365 | |
| (225) 526-0365 |
| Full Name | Dr Daniel E Marsh |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 5238 Dijon Dr, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629075999 | NPI | - | NPPES |
| 1659711 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 11246R (Louisiana) | Primary |
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
A Duke University research team has found a way to help sporting officials detect whether an athlete's blood has been doped by an infusion of their own stored blood.
Researchers from the Laboratory of Cancer Metabolism (LCM) led by George Thomas at the Bellvitge Biomedical Research Institute (IDIBELL), the Catalan Institute of Oncology (ICO) and the Division of Hematology/ Oncology, University of Cincinnati, have shown that loss of either one of two tumor suppressors, ribosomal proteins RPL5 or RPL11, fail to induce cell-cycle arrest, but prevent the proliferation of cells as they have a reduced capacity to synthesize proteins.
Merck Serono, a division of Merck KGaA, and its U.S. affiliate, EMD Serono, Inc. today announced that they are resuming their Stimuvax® (BLP25 liposome vaccine) clinical program in patients with non-small cell lung cancer (NSCLC) which includes the Phase III studies, STARTa and INSPIREb. The treatment and enrollment in these studies will restart after approval by the local regulatory authorities and ethics committees.
With approximately one death occurring every 36 seconds from cardiovascular disease, Americans need to find a way to beat the odds. That premise is the impetus behind Lakewood Regional Medical Center's new campaign, which encourages the community to "Focus on the Heart" by undergoing regular screenings and adopting a heart-healthy lifestyle.
TriReme Medical, Inc. and its affiliates announced today a new round of financing that brings a total of US$18 million into the group.
› Verified 2 days ago
| Entity Name | Renal Associates Of Baton Rouge, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366528135 PECOS PAC ID: 2567354046 Enrollment ID: O20040329000756 |
News Archive
A Duke University research team has found a way to help sporting officials detect whether an athlete's blood has been doped by an infusion of their own stored blood.
Researchers from the Laboratory of Cancer Metabolism (LCM) led by George Thomas at the Bellvitge Biomedical Research Institute (IDIBELL), the Catalan Institute of Oncology (ICO) and the Division of Hematology/ Oncology, University of Cincinnati, have shown that loss of either one of two tumor suppressors, ribosomal proteins RPL5 or RPL11, fail to induce cell-cycle arrest, but prevent the proliferation of cells as they have a reduced capacity to synthesize proteins.
Merck Serono, a division of Merck KGaA, and its U.S. affiliate, EMD Serono, Inc. today announced that they are resuming their Stimuvax® (BLP25 liposome vaccine) clinical program in patients with non-small cell lung cancer (NSCLC) which includes the Phase III studies, STARTa and INSPIREb. The treatment and enrollment in these studies will restart after approval by the local regulatory authorities and ethics committees.
With approximately one death occurring every 36 seconds from cardiovascular disease, Americans need to find a way to beat the odds. That premise is the impetus behind Lakewood Regional Medical Center's new campaign, which encourages the community to "Focus on the Heart" by undergoing regular screenings and adopting a heart-healthy lifestyle.
TriReme Medical, Inc. and its affiliates announced today a new round of financing that brings a total of US$18 million into the group.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel E Marsh, MD Po Box 83130, Baton Rouge, LA 70884-3130 Ph: (225) 767-4893 | Dr Daniel E Marsh, MD 5238 Dijon Dr, Baton Rouge, LA 70808-4311 Ph: (225) 526-0365 |
News Archive
A Duke University research team has found a way to help sporting officials detect whether an athlete's blood has been doped by an infusion of their own stored blood.
Researchers from the Laboratory of Cancer Metabolism (LCM) led by George Thomas at the Bellvitge Biomedical Research Institute (IDIBELL), the Catalan Institute of Oncology (ICO) and the Division of Hematology/ Oncology, University of Cincinnati, have shown that loss of either one of two tumor suppressors, ribosomal proteins RPL5 or RPL11, fail to induce cell-cycle arrest, but prevent the proliferation of cells as they have a reduced capacity to synthesize proteins.
Merck Serono, a division of Merck KGaA, and its U.S. affiliate, EMD Serono, Inc. today announced that they are resuming their Stimuvax® (BLP25 liposome vaccine) clinical program in patients with non-small cell lung cancer (NSCLC) which includes the Phase III studies, STARTa and INSPIREb. The treatment and enrollment in these studies will restart after approval by the local regulatory authorities and ethics committees.
With approximately one death occurring every 36 seconds from cardiovascular disease, Americans need to find a way to beat the odds. That premise is the impetus behind Lakewood Regional Medical Center's new campaign, which encourages the community to "Focus on the Heart" by undergoing regular screenings and adopting a heart-healthy lifestyle.
TriReme Medical, Inc. and its affiliates announced today a new round of financing that brings a total of US$18 million into the group.
› Verified 2 days ago
Dr. Jennifer L Rippon, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 7777 Hennessy Blvd Ste 409, Baton Rouge, LA 70808 Phone: 225-765-5864 Fax: 225-765-2013 | |
Gregory Fusilier, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 9103 Jefferson Hwy, Baton Rouge, LA 70809 Phone: 225-927-1190 Fax: 225-927-0988 | |
Dr. Yolanda Maria O'rourke, Nephrology Medicare: Not Enrolled in Medicare Practice Location: 7968 Essen Park, Baton Rouge, LA 70809 Phone: 225-761-6700 Fax: 225-761-6760 | |
Patricia D. Whatley, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 7373 Perkins Rd, Attn: Dee / Administration, Baton Rouge, LA 70808 Phone: 225-769-4044 | |
Frederick Cerise, Nephrology Medicare: Not Enrolled in Medicare Practice Location: 3810 W Lakeshore Dr, Baton Rouge, LA 70808 Phone: 225-578-8886 | |
Dr. Jon Richard Jackson, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5000 Hennessy Blvd, Baton Rouge, LA 70808 Phone: 225-765-4050 Fax: 225-765-4046 | |
Richard Frank Burroughs, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: Earl K. Long Hospital, Lsu Unit, 5825 Airline Highway, Baton Rouge, LA 70805 Phone: 225-358-3938 |